Llwytho...
Treatment of early-stage HER2+ breast cancer—an evolving field
The evolving field of HER2-targeted therapy has significantly improved the outcome of women diagnosed with HER2-positive invasive breast cancer. In this review, we sought to summarise the efficacy of trastuzumab-based regimens in the adjuvant and neoadjuvant setting with a special emphasis on releva...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ecancermedicalscience |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Cancer Intelligence
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406526/ https://ncbi.nlm.nih.gov/pubmed/25932047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.523 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|